As already indicated by the description of the partly very different effects of IL-17A and IL-17F on CRC pathogenesis, it is obviously far too simplistic to automatically conclude from the pro-tumorigenic effect of IL-17A that an increased presence of Th17 cells in tumor tissue might be an indicator of poor disease prognosis. The gene discussed is IL17F; the disease is neoplasm.